Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
BOOK REVIEW
Year : 2007  |  Volume : 3  |  Issue : 1  |  Page : 68

Filgrastim (r-methug-CSF) in practice: Second edition


Chief Radiation Oncologist, Dr. Balabhai Nanavati Hospital, S.V. Road, Vile Parle (W), Mumbai - 400 056, India

Correspondence Address:
Nagraj G Huilgol
Chief Radiation Oncologist, Dr. Balabhai Nanavati Hospital, S.V. Road, Vile Parle (W), Mumbai - 400 056
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Huilgol NG. Filgrastim (r-methug-CSF) in practice: Second edition. J Can Res Ther 2007;3:68

How to cite this URL:
Huilgol NG. Filgrastim (r-methug-CSF) in practice: Second edition. J Can Res Ther [serial online] 2007 [cited 2019 Nov 20];3:68. Available from: http://www.cancerjournal.net/text.asp?2007/3/1/68/31978

George Morstyn, T Michael Dexter, Maryann Foote

Publisher: Marcel Dekker

Nagraj G Huilgol


Chief Radiation Oncologist, Dr. Balabhai Nanavati Hospital,

S.V. Road, Vile Parle (W), Mumbai - 400 056, India.

E-mail: nagrajh@vsnl.net

The book edited by G Moostyn, TM Bexter and Foote was first published in 1998. This is the second improved edition. Introduction of filgrastim and other growth factors have influenced the practice of chemotherapy. There was a lack of monogram dealing with CSF comprehensively. This book fills in the need for a complete monogram. The book has six chapters. The first deals with biology, pharmacology and biochemistry of filgrastim. Later chapters deal with newer indications of filgrastim like autoimmune disease, diabetic foot ulcers and infection. The concluding chapters deal with practical aspects of dose, techniques of administration and indications. The emphasis of the book is on the direct relation between cumulative chemotherapy dose and eventual survival. It can be construed as an effort to rationalise dose escalation with CSF. The chapter dealing with filgrastim in pneumonia deals with the use of the drug in treatment of nonneutropenic infections disease such as neonatal sepsis, pneumonia, burn wounds and intractable intraabdominal sepsis.

Editors have covered extensively the use of CSF. May be negative trial of CSF as radiation protector and early reports of potential for thermal senstisation could have been included.

Filgrastim in clinical practice is an excellent reference book for oncologists. It is an extremely readable book with consistent style.


    Figures

  [Figure - 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  >Article Figures
  In this article

 Article Access Statistics
    Viewed2902    
    Printed119    
    Emailed0    
    PDF Downloaded235    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]